Instructors
Jaclyn Bosco, PhD, MPH, FISPE
Vice President and Global Head of Epidemiology, IQVIA, United States
Dr. Jaclyn Bosco Global Head of Epidemiology in Real World Solutions at IQVIA, is responsible for driving real-world evidence (RWE) generation for regulators, clinicians, patients and payers using passive and primary data collection through clinicians and person-generated health to support the safety and effectiveness of drugs, biologics, and medical devices from early clinical development through the post-approval phase. She identifies the best approach for capturing data on a global scale as well applies local approaches to address market-specific needs. As a thought leader in real world research, she is invited to speak at international congresses and sits on scientific advisory boards and committees.
![Emily Castellanos, MD, MPH](/_Images/member/Generic_Image_Missing-Profile.jpg)
Emily Castellanos, MD, MPH
Senior Medical Director, Research Oncology, Flatiron Health, United States
Emily Castellanos is a medical oncologist and hematologist who serves as medical director at Flatiron Health, where she leverages her clinical and research expertise to develop innovative approaches to real-world evidence generation and inform product strategy. She has a special interest in integrated approaches to real-world data, such as clinico-genomics, clinico-claims, or imaging data, as well as novel approaches to real-world study design.
![Jonathan Assayag, DrSc, PhD, MSc](/_Images/member/Generic_Image_Missing-Profile.jpg)
Jonathan Assayag, DrSc, PhD, MSc
Director, RWE Scientist Oncology, RWE Platform, Pfizer, Canada
Jonathan is a Director and RWE Scientist in the RWE Center of Excellence at Pfizer, where he designs and executes on RWE strategy and works with teams across the drug development lifecycle. Jonathan has more than 10 years’ experience utilizing real-world and clinical data to conduct and communicate healthcare research. His prior work includes working in medical affairs where he also led RWE education initiatives for Pfizer colleagues. Jonathan holds a PhD from McGill University in Pharmacoepidemiology where he is also currently an instructor in the department of Medicine.
¿Tiene una cuenta?